|
REVB Revelation Biosciences Inc 1810560 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,323,384.00 |
| Balance Sheet |
|
Current Assets
|
$11,684,516.00 |
|
Assets
|
$12,497,932.00 |
|
Current Liabilities
|
$1,880,400.00 |
|
Liabilities
|
$2,430,946.00 |
|
Equity
|
$10,066,986.00 |
|
Shares Out
|
3908420.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,772,044.00 |
|
Investing Cash Flow
|
$-111,507.00 |
| Market Analysis |
Market Cap
|
$4,182,009.40 |
|
Price
|
$1.07 |
|
BVPS
|
2.58 |
|
PB
|
0.41 |
|
EPS
|
-0.87 |
|
FCF
|
$-5,883,551.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-1.65 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-2.71 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-08 |
-7.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.77 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view REVB documents filed with the SEC.
REVB Filings
Clear
